nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ABCB1—colon cancer	0.268	1	CbGaD
Liotrix—SLCO4C1—Methotrexate—colon cancer	0.13	0.234	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—colon cancer	0.0913	0.165	CbGbCtD
Liotrix—SLCO1B1—Irinotecan—colon cancer	0.0561	0.101	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—colon cancer	0.051	0.0919	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—colon cancer	0.0315	0.0567	CbGbCtD
Liotrix—ALB—Irinotecan—colon cancer	0.0307	0.0554	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—colon cancer	0.0297	0.0535	CbGbCtD
Liotrix—ALB—Fluorouracil—colon cancer	0.0295	0.0531	CbGbCtD
Liotrix—SLC22A8—Methotrexate—colon cancer	0.0274	0.0494	CbGbCtD
Liotrix—CYP2C8—Fluorouracil—colon cancer	0.0228	0.0411	CbGbCtD
Liotrix—ALB—Methotrexate—colon cancer	0.0163	0.0293	CbGbCtD
Liotrix—ABCB1—Irinotecan—colon cancer	0.0161	0.029	CbGbCtD
Liotrix—ABCB1—Vincristine—colon cancer	0.0141	0.0253	CbGbCtD
Liotrix—SLC10A1—bile—colon cancer	0.0118	0.171	CbGeAlD
Liotrix—ABCB1—Methotrexate—colon cancer	0.00851	0.0153	CbGbCtD
Liotrix—SERPINA7—bone marrow—colon cancer	0.00217	0.0316	CbGeAlD
Liotrix—SLCO4C1—renal system—colon cancer	0.00185	0.0269	CbGeAlD
Liotrix—THRA—renal system—colon cancer	0.00177	0.0258	CbGeAlD
Liotrix—THRB—renal system—colon cancer	0.00177	0.0258	CbGeAlD
Liotrix—SERPINA7—liver—colon cancer	0.00175	0.0255	CbGeAlD
Liotrix—ALB—gall bladder—colon cancer	0.00175	0.0255	CbGeAlD
Liotrix—TTR—embryo—colon cancer	0.00174	0.0253	CbGeAlD
Liotrix—SLC10A1—renal system—colon cancer	0.00157	0.0228	CbGeAlD
Liotrix—SLCO1C1—renal system—colon cancer	0.00147	0.0215	CbGeAlD
Liotrix—SLCO4C1—bone marrow—colon cancer	0.0014	0.0203	CbGeAlD
Liotrix—SLCO4C1—vagina—colon cancer	0.00134	0.0195	CbGeAlD
Liotrix—TTR—renal system—colon cancer	0.00132	0.0192	CbGeAlD
Liotrix—SLCO1B3—vagina—colon cancer	0.0013	0.0189	CbGeAlD
Liotrix—SLC10A1—digestive system—colon cancer	0.00129	0.0187	CbGeAlD
Liotrix—THRB—vagina—colon cancer	0.00128	0.0187	CbGeAlD
Liotrix—SLCO4A1—renal system—colon cancer	0.00118	0.0172	CbGeAlD
Liotrix—SLC16A2—vagina—colon cancer	0.00116	0.0169	CbGeAlD
Liotrix—SLCO4C1—liver—colon cancer	0.00113	0.0164	CbGeAlD
Liotrix—SLC16A10—epithelium—colon cancer	0.00112	0.0163	CbGeAlD
Liotrix—SLCO1B3—liver—colon cancer	0.0011	0.016	CbGeAlD
Liotrix—TTR—lymphoid tissue—colon cancer	0.00109	0.0159	CbGeAlD
Liotrix—THRB—liver—colon cancer	0.00108	0.0158	CbGeAlD
Liotrix—THRA—liver—colon cancer	0.00108	0.0158	CbGeAlD
Liotrix—TTR—digestive system—colon cancer	0.00108	0.0157	CbGeAlD
Liotrix—SLCO1B1—renal system—colon cancer	0.00104	0.0151	CbGeAlD
Liotrix—TTR—bone marrow—colon cancer	0.000997	0.0145	CbGeAlD
Liotrix—SLC16A2—liver—colon cancer	0.000982	0.0143	CbGeAlD
Liotrix—SLCO4A1—digestive system—colon cancer	0.000969	0.0141	CbGeAlD
Liotrix—SLC10A1—liver—colon cancer	0.000958	0.0139	CbGeAlD
Liotrix—SLC16A10—lymphoid tissue—colon cancer	0.00086	0.0125	CbGeAlD
Liotrix—SLCO4A1—vagina—colon cancer	0.000856	0.0125	CbGeAlD
Liotrix—SLCO1B1—digestive system—colon cancer	0.000853	0.0124	CbGeAlD
Liotrix—SLCO1A2—renal system—colon cancer	0.000846	0.0123	CbGeAlD
Liotrix—THRA—lymph node—colon cancer	0.000831	0.0121	CbGeAlD
Liotrix—THRB—lymph node—colon cancer	0.000831	0.0121	CbGeAlD
Liotrix—SLC22A8—renal system—colon cancer	0.000808	0.0118	CbGeAlD
Liotrix—TTR—liver—colon cancer	0.000806	0.0117	CbGeAlD
Liotrix—SLC16A2—lymph node—colon cancer	0.000753	0.011	CbGeAlD
Liotrix—SLC16A10—vagina—colon cancer	0.000751	0.0109	CbGeAlD
Liotrix—SLCO4A1—liver—colon cancer	0.000722	0.0105	CbGeAlD
Liotrix—Levothyroxine—ABCB1—colon cancer	0.000704	0.584	CrCbGaD
Liotrix—SLCO1A2—digestive system—colon cancer	0.000694	0.0101	CbGeAlD
Liotrix—SLCO1C1—lymph node—colon cancer	0.000691	0.01	CbGeAlD
Liotrix—Sepsis—Irinotecan—colon cancer	0.000686	0.00705	CcSEcCtD
Liotrix—Coagulopathy—Capecitabine—colon cancer	0.000679	0.00698	CcSEcCtD
Liotrix—Tingling sensation—Capecitabine—colon cancer	0.000658	0.00676	CcSEcCtD
Liotrix—Sepsis—Fluorouracil—colon cancer	0.000657	0.00675	CcSEcCtD
Liotrix—SLCO1B1—liver—colon cancer	0.000635	0.00924	CbGeAlD
Liotrix—SLC16A10—liver—colon cancer	0.000633	0.00921	CbGeAlD
Liotrix—ABCB1—blood vessel—colon cancer	0.000628	0.00913	CbGeAlD
Liotrix—Swelling—Fluorouracil—colon cancer	0.000623	0.0064	CcSEcCtD
Liotrix—Renal failure acute—Irinotecan—colon cancer	0.000621	0.00638	CcSEcCtD
Liotrix—Disorientation—Fluorouracil—colon cancer	0.000614	0.00631	CcSEcCtD
Liotrix—THRA—Nuclear Receptors—HNF4A—colon cancer	0.00061	0.0609	CbGpPWpGaD
Liotrix—THRB—Nuclear Receptors—HNF4A—colon cancer	0.00061	0.0609	CbGpPWpGaD
Liotrix—Renal impairment—Irinotecan—colon cancer	0.000603	0.00619	CcSEcCtD
Liotrix—CYP2C8—renal system—colon cancer	0.000591	0.0086	CbGeAlD
Liotrix—Cerebrovascular accident—Irinotecan—colon cancer	0.000585	0.00601	CcSEcCtD
Liotrix—Cellulitis—Capecitabine—colon cancer	0.000582	0.00598	CcSEcCtD
Liotrix—Hypocalcaemia—Capecitabine—colon cancer	0.000578	0.00594	CcSEcCtD
Liotrix—Cardiac failure—Fluorouracil—colon cancer	0.000563	0.00578	CcSEcCtD
Liotrix—Cardiac arrest—Vincristine—colon cancer	0.00056	0.00575	CcSEcCtD
Liotrix—Ulcer—Capecitabine—colon cancer	0.000559	0.00574	CcSEcCtD
Liotrix—Cyanosis—Methotrexate—colon cancer	0.000556	0.00571	CcSEcCtD
Liotrix—SLCO4A1—lymph node—colon cancer	0.000554	0.00805	CbGeAlD
Liotrix—Dehydration—Vincristine—colon cancer	0.000548	0.00563	CcSEcCtD
Liotrix—Cardiac arrest—Irinotecan—colon cancer	0.000545	0.0056	CcSEcCtD
Liotrix—Blood creatinine increased—Irinotecan—colon cancer	0.000537	0.00552	CcSEcCtD
Liotrix—Dehydration—Irinotecan—colon cancer	0.000533	0.00548	CcSEcCtD
Liotrix—Irritability—Fluorouracil—colon cancer	0.000524	0.00539	CcSEcCtD
Liotrix—Cardiac arrest—Fluorouracil—colon cancer	0.000522	0.00537	CcSEcCtD
Liotrix—Hypokalaemia—Irinotecan—colon cancer	0.000522	0.00536	CcSEcCtD
Liotrix—Muscular weakness—Vincristine—colon cancer	0.000519	0.00534	CcSEcCtD
Liotrix—SLCO1A2—liver—colon cancer	0.000517	0.00752	CbGeAlD
Liotrix—ALB—liver—colon cancer	0.000514	0.00748	CbGeAlD
Liotrix—SLC10A1—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000511	0.051	CbGpPWpGaD
Liotrix—Fluid retention—Capecitabine—colon cancer	0.000502	0.00516	CcSEcCtD
Liotrix—Liothyronine—ABCB1—colon cancer	0.000502	0.416	CrCbGaD
Liotrix—Necrosis—Methotrexate—colon cancer	0.000502	0.00515	CcSEcCtD
Liotrix—Abdominal distension—Irinotecan—colon cancer	0.000499	0.00513	CcSEcCtD
Liotrix—Abscess—Methotrexate—colon cancer	0.000498	0.00511	CcSEcCtD
Liotrix—SLC16A10—lymph node—colon cancer	0.000485	0.00706	CbGeAlD
Liotrix—Muscular weakness—Fluorouracil—colon cancer	0.000484	0.00498	CcSEcCtD
Liotrix—Sweating increased—Irinotecan—colon cancer	0.000483	0.00496	CcSEcCtD
Liotrix—Angina pectoris—Irinotecan—colon cancer	0.000483	0.00496	CcSEcCtD
Liotrix—THRA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000482	0.0481	CbGpPWpGaD
Liotrix—THRB—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000482	0.0481	CbGpPWpGaD
Liotrix—Dysphagia—Fluorouracil—colon cancer	0.000475	0.00488	CcSEcCtD
Liotrix—Angina pectoris—Fluorouracil—colon cancer	0.000462	0.00475	CcSEcCtD
Liotrix—Weight decreased—Vincristine—colon cancer	0.000461	0.00473	CcSEcCtD
Liotrix—Sepsis—Capecitabine—colon cancer	0.000459	0.00472	CcSEcCtD
Liotrix—Extravasation—Methotrexate—colon cancer	0.000451	0.00464	CcSEcCtD
Liotrix—Weight decreased—Irinotecan—colon cancer	0.000448	0.00461	CcSEcCtD
Liotrix—Acute coronary syndrome—Vincristine—colon cancer	0.000447	0.0046	CcSEcCtD
Liotrix—Phlebitis—Capecitabine—colon cancer	0.000446	0.00458	CcSEcCtD
Liotrix—Myocardial infarction—Vincristine—colon cancer	0.000445	0.00457	CcSEcCtD
Liotrix—Acute coronary syndrome—Irinotecan—colon cancer	0.000436	0.00448	CcSEcCtD
Liotrix—Swelling—Capecitabine—colon cancer	0.000435	0.00447	CcSEcCtD
Liotrix—Sweating—Vincristine—colon cancer	0.000435	0.00447	CcSEcCtD
Liotrix—Renal failure—Irinotecan—colon cancer	0.000434	0.00446	CcSEcCtD
Liotrix—Myocardial infarction—Irinotecan—colon cancer	0.000433	0.00445	CcSEcCtD
Liotrix—CYP2C8—vagina—colon cancer	0.000428	0.00623	CbGeAlD
Liotrix—Oliguria—Methotrexate—colon cancer	0.000427	0.00439	CcSEcCtD
Liotrix—Sweating—Irinotecan—colon cancer	0.000424	0.00435	CcSEcCtD
Liotrix—Acute coronary syndrome—Fluorouracil—colon cancer	0.000417	0.00429	CcSEcCtD
Liotrix—Ulcer—Methotrexate—colon cancer	0.000416	0.00428	CcSEcCtD
Liotrix—Renal failure acute—Capecitabine—colon cancer	0.000416	0.00427	CcSEcCtD
Liotrix—Myocardial infarction—Fluorouracil—colon cancer	0.000415	0.00426	CcSEcCtD
Liotrix—Increased appetite—Capecitabine—colon cancer	0.000409	0.0042	CcSEcCtD
Liotrix—Hypoaesthesia—Vincristine—colon cancer	0.000405	0.00417	CcSEcCtD
Liotrix—Renal impairment—Capecitabine—colon cancer	0.000403	0.00414	CcSEcCtD
Liotrix—ALB—lymph node—colon cancer	0.000394	0.00573	CbGeAlD
Liotrix—Cardiac failure—Capecitabine—colon cancer	0.000393	0.00404	CcSEcCtD
Liotrix—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000393	0.0392	CbGpPWpGaD
Liotrix—Cerebrovascular accident—Capecitabine—colon cancer	0.000392	0.00403	CcSEcCtD
Liotrix—TTR—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.000387	0.0386	CbGpPWpGaD
Liotrix—Hypoaesthesia—Fluorouracil—colon cancer	0.000378	0.00389	CcSEcCtD
Liotrix—ABCB1—embryo—colon cancer	0.000375	0.00545	CbGeAlD
Liotrix—Flushing—Irinotecan—colon cancer	0.000368	0.00378	CcSEcCtD
Liotrix—Irritability—Capecitabine—colon cancer	0.000366	0.00376	CcSEcCtD
Liotrix—Cardiac arrest—Capecitabine—colon cancer	0.000365	0.00375	CcSEcCtD
Liotrix—Mood swings—Capecitabine—colon cancer	0.000364	0.00374	CcSEcCtD
Liotrix—CYP2C8—liver—colon cancer	0.000361	0.00526	CbGeAlD
Liotrix—Alopecia—Vincristine—colon cancer	0.00036	0.0037	CcSEcCtD
Liotrix—Coma—Methotrexate—colon cancer	0.00036	0.0037	CcSEcCtD
Liotrix—Blood creatinine increased—Capecitabine—colon cancer	0.00036	0.0037	CcSEcCtD
Liotrix—THRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.000359	0.0358	CbGpPWpGaD
Liotrix—THRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.000359	0.0358	CbGpPWpGaD
Liotrix—Dehydration—Capecitabine—colon cancer	0.000357	0.00367	CcSEcCtD
Liotrix—Arrhythmia—Irinotecan—colon cancer	0.000354	0.00364	CcSEcCtD
Liotrix—Alopecia—Irinotecan—colon cancer	0.000351	0.0036	CcSEcCtD
Liotrix—Hypokalaemia—Capecitabine—colon cancer	0.000349	0.00359	CcSEcCtD
Liotrix—Sepsis—Methotrexate—colon cancer	0.000342	0.00351	CcSEcCtD
Liotrix—Flatulence—Irinotecan—colon cancer	0.00034	0.0035	CcSEcCtD
Liotrix—Arrhythmia—Fluorouracil—colon cancer	0.000339	0.00349	CcSEcCtD
Liotrix—Muscular weakness—Capecitabine—colon cancer	0.000339	0.00348	CcSEcCtD
Liotrix—Alopecia—Fluorouracil—colon cancer	0.000336	0.00345	CcSEcCtD
Liotrix—Abdominal distension—Capecitabine—colon cancer	0.000334	0.00343	CcSEcCtD
Liotrix—Dysphagia—Capecitabine—colon cancer	0.000332	0.00341	CcSEcCtD
Liotrix—Bronchospasm—Capecitabine—colon cancer	0.000326	0.00335	CcSEcCtD
Liotrix—Agitation—Vincristine—colon cancer	0.000326	0.00335	CcSEcCtD
Liotrix—Sweating increased—Capecitabine—colon cancer	0.000323	0.00332	CcSEcCtD
Liotrix—Angina pectoris—Capecitabine—colon cancer	0.000323	0.00332	CcSEcCtD
Liotrix—Bronchitis—Capecitabine—colon cancer	0.000319	0.00328	CcSEcCtD
Liotrix—Vision blurred—Fluorouracil—colon cancer	0.000312	0.0032	CcSEcCtD
Liotrix—Syncope—Irinotecan—colon cancer	0.00031	0.00318	CcSEcCtD
Liotrix—Renal failure acute—Methotrexate—colon cancer	0.00031	0.00318	CcSEcCtD
Liotrix—Convulsion—Vincristine—colon cancer	0.000307	0.00316	CcSEcCtD
Liotrix—Hypertension—Vincristine—colon cancer	0.000306	0.00315	CcSEcCtD
Liotrix—ABCB1—epithelium—colon cancer	0.000306	0.00445	CbGeAlD
Liotrix—Loss of consciousness—Irinotecan—colon cancer	0.000304	0.00312	CcSEcCtD
Liotrix—Weight decreased—Capecitabine—colon cancer	0.0003	0.00308	CcSEcCtD
Liotrix—Hypertension—Irinotecan—colon cancer	0.000298	0.00306	CcSEcCtD
Liotrix—Acute coronary syndrome—Capecitabine—colon cancer	0.000292	0.003	CcSEcCtD
Liotrix—Cerebrovascular accident—Methotrexate—colon cancer	0.000292	0.003	CcSEcCtD
Liotrix—Renal failure—Capecitabine—colon cancer	0.000291	0.00299	CcSEcCtD
Liotrix—Myocardial infarction—Capecitabine—colon cancer	0.00029	0.00298	CcSEcCtD
Liotrix—Oedema—Vincristine—colon cancer	0.000289	0.00297	CcSEcCtD
Liotrix—Anaphylactic shock—Vincristine—colon cancer	0.000289	0.00297	CcSEcCtD
Liotrix—Infection—Vincristine—colon cancer	0.000288	0.00295	CcSEcCtD
Liotrix—Convulsion—Fluorouracil—colon cancer	0.000287	0.00295	CcSEcCtD
Liotrix—Confusional state—Irinotecan—colon cancer	0.000284	0.00292	CcSEcCtD
Liotrix—ABCB1—renal system—colon cancer	0.000284	0.00412	CbGeAlD
Liotrix—Anaphylactic shock—Irinotecan—colon cancer	0.000282	0.0029	CcSEcCtD
Liotrix—Oedema—Irinotecan—colon cancer	0.000282	0.0029	CcSEcCtD
Liotrix—Chest pain—Fluorouracil—colon cancer	0.000282	0.00289	CcSEcCtD
Liotrix—Infection—Irinotecan—colon cancer	0.00028	0.00288	CcSEcCtD
Liotrix—Hyperhidrosis—Vincristine—colon cancer	0.00028	0.00288	CcSEcCtD
Liotrix—Shock—Irinotecan—colon cancer	0.000277	0.00285	CcSEcCtD
Liotrix—Anorexia—Vincristine—colon cancer	0.000276	0.00284	CcSEcCtD
Liotrix—Irritability—Methotrexate—colon cancer	0.000273	0.0028	CcSEcCtD
Liotrix—Hyperhidrosis—Irinotecan—colon cancer	0.000273	0.0028	CcSEcCtD
Liotrix—Confusional state—Fluorouracil—colon cancer	0.000272	0.0028	CcSEcCtD
Liotrix—Mood swings—Methotrexate—colon cancer	0.000271	0.00278	CcSEcCtD
Liotrix—Hypotension—Vincristine—colon cancer	0.00027	0.00278	CcSEcCtD
Liotrix—Oedema—Fluorouracil—colon cancer	0.00027	0.00277	CcSEcCtD
Liotrix—Anaphylactic shock—Fluorouracil—colon cancer	0.00027	0.00277	CcSEcCtD
Liotrix—Anorexia—Irinotecan—colon cancer	0.000269	0.00276	CcSEcCtD
Liotrix—Infection—Fluorouracil—colon cancer	0.000268	0.00276	CcSEcCtD
Liotrix—THRB—Nuclear Receptors—PPARG—colon cancer	0.000265	0.0264	CbGpPWpGaD
Liotrix—THRA—Nuclear Receptors—PPARG—colon cancer	0.000265	0.0264	CbGpPWpGaD
Liotrix—Hypoaesthesia—Capecitabine—colon cancer	0.000264	0.00271	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Vincristine—colon cancer	0.000264	0.00271	CcSEcCtD
Liotrix—Tachycardia—Fluorouracil—colon cancer	0.000263	0.00271	CcSEcCtD
Liotrix—Hypotension—Irinotecan—colon cancer	0.000263	0.00271	CcSEcCtD
Liotrix—Insomnia—Vincristine—colon cancer	0.000262	0.00269	CcSEcCtD
Liotrix—Paraesthesia—Vincristine—colon cancer	0.00026	0.00267	CcSEcCtD
Liotrix—Anorexia—Fluorouracil—colon cancer	0.000257	0.00264	CcSEcCtD
Liotrix—Insomnia—Irinotecan—colon cancer	0.000255	0.00262	CcSEcCtD
Liotrix—Paraesthesia—Irinotecan—colon cancer	0.000253	0.0026	CcSEcCtD
Liotrix—Hypotension—Fluorouracil—colon cancer	0.000252	0.00259	CcSEcCtD
Liotrix—Decreased appetite—Vincristine—colon cancer	0.000252	0.00259	CcSEcCtD
Liotrix—Dyspnoea—Irinotecan—colon cancer	0.000251	0.00258	CcSEcCtD
Liotrix—Fatigue—Vincristine—colon cancer	0.00025	0.00256	CcSEcCtD
Liotrix—Constipation—Vincristine—colon cancer	0.000248	0.00254	CcSEcCtD
Liotrix—Flushing—Capecitabine—colon cancer	0.000246	0.00253	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000246	0.00253	CcSEcCtD
Liotrix—Decreased appetite—Irinotecan—colon cancer	0.000245	0.00252	CcSEcCtD
Liotrix—Insomnia—Fluorouracil—colon cancer	0.000244	0.00251	CcSEcCtD
Liotrix—Fatigue—Irinotecan—colon cancer	0.000243	0.0025	CcSEcCtD
Liotrix—Paraesthesia—Fluorouracil—colon cancer	0.000242	0.00249	CcSEcCtD
Liotrix—Constipation—Irinotecan—colon cancer	0.000241	0.00248	CcSEcCtD
Liotrix—Dyspnoea—Fluorouracil—colon cancer	0.000241	0.00247	CcSEcCtD
Liotrix—Arrhythmia—Capecitabine—colon cancer	0.000237	0.00244	CcSEcCtD
Liotrix—Gastrointestinal pain—Vincristine—colon cancer	0.000237	0.00243	CcSEcCtD
Liotrix—ABCB1—lymphoid tissue—colon cancer	0.000235	0.00342	CbGeAlD
Liotrix—Decreased appetite—Fluorouracil—colon cancer	0.000235	0.00241	CcSEcCtD
Liotrix—Alopecia—Capecitabine—colon cancer	0.000235	0.00241	CcSEcCtD
Liotrix—ABCB1—digestive system—colon cancer	0.000233	0.00338	CbGeAlD
Liotrix—Feeling abnormal—Irinotecan—colon cancer	0.000232	0.00239	CcSEcCtD
Liotrix—Gastrointestinal pain—Irinotecan—colon cancer	0.000231	0.00237	CcSEcCtD
Liotrix—Body temperature increased—Vincristine—colon cancer	0.000229	0.00235	CcSEcCtD
Liotrix—Abdominal pain—Vincristine—colon cancer	0.000229	0.00235	CcSEcCtD
Liotrix—Flatulence—Capecitabine—colon cancer	0.000228	0.00234	CcSEcCtD
Liotrix—Dysgeusia—Capecitabine—colon cancer	0.000226	0.00233	CcSEcCtD
Liotrix—Abdominal pain—Irinotecan—colon cancer	0.000223	0.00229	CcSEcCtD
Liotrix—Body temperature increased—Irinotecan—colon cancer	0.000223	0.00229	CcSEcCtD
Liotrix—Feeling abnormal—Fluorouracil—colon cancer	0.000222	0.00229	CcSEcCtD
Liotrix—Vision blurred—Capecitabine—colon cancer	0.000218	0.00224	CcSEcCtD
Liotrix—Tremor—Capecitabine—colon cancer	0.000217	0.00223	CcSEcCtD
Liotrix—Renal failure—Methotrexate—colon cancer	0.000216	0.00222	CcSEcCtD
Liotrix—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000215	0.0214	CbGpPWpGaD
Liotrix—Urticaria—Fluorouracil—colon cancer	0.000214	0.0022	CcSEcCtD
Liotrix—ABCB1—bone marrow—colon cancer	0.000214	0.00312	CbGeAlD
Liotrix—Body temperature increased—Fluorouracil—colon cancer	0.000213	0.00219	CcSEcCtD
Liotrix—Hypersensitivity—Vincristine—colon cancer	0.000213	0.00219	CcSEcCtD
Liotrix—Sweating—Methotrexate—colon cancer	0.000211	0.00217	CcSEcCtD
Liotrix—THRA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000209	0.0209	CbGpPWpGaD
Liotrix—THRB—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000209	0.0209	CbGpPWpGaD
Liotrix—Hypersensitivity—Irinotecan—colon cancer	0.000208	0.00213	CcSEcCtD
Liotrix—Asthenia—Vincristine—colon cancer	0.000208	0.00213	CcSEcCtD
Liotrix—Syncope—Capecitabine—colon cancer	0.000207	0.00213	CcSEcCtD
Liotrix—ABCB1—vagina—colon cancer	0.000205	0.00299	CbGeAlD
Liotrix—Palpitations—Capecitabine—colon cancer	0.000204	0.0021	CcSEcCtD
Liotrix—THRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.000204	0.0204	CbGpPWpGaD
Liotrix—THRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.000204	0.0204	CbGpPWpGaD
Liotrix—Loss of consciousness—Capecitabine—colon cancer	0.000203	0.00209	CcSEcCtD
Liotrix—Asthenia—Irinotecan—colon cancer	0.000202	0.00208	CcSEcCtD
Liotrix—Hypertension—Capecitabine—colon cancer	0.0002	0.00205	CcSEcCtD
Liotrix—Hypersensitivity—Fluorouracil—colon cancer	0.000199	0.00204	CcSEcCtD
Liotrix—Diarrhoea—Vincristine—colon cancer	0.000198	0.00203	CcSEcCtD
Liotrix—THRA—Endochondral Ossification—FGFR3—colon cancer	0.000197	0.0197	CbGpPWpGaD
Liotrix—Arthralgia—Capecitabine—colon cancer	0.000197	0.00202	CcSEcCtD
Liotrix—Chest pain—Capecitabine—colon cancer	0.000197	0.00202	CcSEcCtD
Liotrix—Anxiety—Capecitabine—colon cancer	0.000196	0.00202	CcSEcCtD
Liotrix—Diarrhoea—Irinotecan—colon cancer	0.000193	0.00198	CcSEcCtD
Liotrix—Dizziness—Vincristine—colon cancer	0.000191	0.00197	CcSEcCtD
Liotrix—Pruritus—Fluorouracil—colon cancer	0.000191	0.00196	CcSEcCtD
Liotrix—Confusional state—Capecitabine—colon cancer	0.00019	0.00195	CcSEcCtD
Liotrix—Oedema—Capecitabine—colon cancer	0.000189	0.00194	CcSEcCtD
Liotrix—Infection—Capecitabine—colon cancer	0.000187	0.00193	CcSEcCtD
Liotrix—Dizziness—Irinotecan—colon cancer	0.000186	0.00192	CcSEcCtD
Liotrix—Shock—Capecitabine—colon cancer	0.000186	0.00191	CcSEcCtD
Liotrix—Diarrhoea—Fluorouracil—colon cancer	0.000185	0.0019	CcSEcCtD
Liotrix—Tachycardia—Capecitabine—colon cancer	0.000184	0.00189	CcSEcCtD
Liotrix—Vomiting—Vincristine—colon cancer	0.000184	0.00189	CcSEcCtD
Liotrix—Rash—Vincristine—colon cancer	0.000183	0.00188	CcSEcCtD
Liotrix—Hyperhidrosis—Capecitabine—colon cancer	0.000182	0.00187	CcSEcCtD
Liotrix—Dermatitis—Vincristine—colon cancer	0.000182	0.00187	CcSEcCtD
Liotrix—Headache—Vincristine—colon cancer	0.000181	0.00186	CcSEcCtD
Liotrix—SLCO1B1—Irinotecan Pathway—APC—colon cancer	0.000181	0.0181	CbGpPWpGaD
Liotrix—Anorexia—Capecitabine—colon cancer	0.00018	0.00185	CcSEcCtD
Liotrix—Vomiting—Irinotecan—colon cancer	0.000179	0.00184	CcSEcCtD
Liotrix—Dizziness—Fluorouracil—colon cancer	0.000179	0.00183	CcSEcCtD
Liotrix—Rash—Irinotecan—colon cancer	0.000178	0.00183	CcSEcCtD
Liotrix—Dermatitis—Irinotecan—colon cancer	0.000178	0.00182	CcSEcCtD
Liotrix—Headache—Irinotecan—colon cancer	0.000177	0.00181	CcSEcCtD
Liotrix—Hypotension—Capecitabine—colon cancer	0.000176	0.00181	CcSEcCtD
Liotrix—Alopecia—Methotrexate—colon cancer	0.000175	0.00179	CcSEcCtD
Liotrix—ABCB1—liver—colon cancer	0.000173	0.00252	CbGeAlD
Liotrix—Nausea—Vincristine—colon cancer	0.000172	0.00177	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000172	0.00177	CcSEcCtD
Liotrix—Vomiting—Fluorouracil—colon cancer	0.000172	0.00176	CcSEcCtD
Liotrix—Insomnia—Capecitabine—colon cancer	0.000171	0.00175	CcSEcCtD
Liotrix—Rash—Fluorouracil—colon cancer	0.00017	0.00175	CcSEcCtD
Liotrix—Dermatitis—Fluorouracil—colon cancer	0.00017	0.00175	CcSEcCtD
Liotrix—Paraesthesia—Capecitabine—colon cancer	0.000169	0.00174	CcSEcCtD
Liotrix—Headache—Fluorouracil—colon cancer	0.000169	0.00174	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—colon cancer	0.000169	0.00173	CcSEcCtD
Liotrix—Dyspnoea—Capecitabine—colon cancer	0.000168	0.00173	CcSEcCtD
Liotrix—Nausea—Irinotecan—colon cancer	0.000167	0.00172	CcSEcCtD
Liotrix—Decreased appetite—Capecitabine—colon cancer	0.000164	0.00169	CcSEcCtD
Liotrix—Fatigue—Capecitabine—colon cancer	0.000163	0.00167	CcSEcCtD
Liotrix—Vision blurred—Methotrexate—colon cancer	0.000162	0.00167	CcSEcCtD
Liotrix—Constipation—Capecitabine—colon cancer	0.000161	0.00166	CcSEcCtD
Liotrix—Nausea—Fluorouracil—colon cancer	0.00016	0.00165	CcSEcCtD
Liotrix—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000158	0.0157	CbGpPWpGaD
Liotrix—Feeling abnormal—Capecitabine—colon cancer	0.000155	0.0016	CcSEcCtD
Liotrix—Gastrointestinal pain—Capecitabine—colon cancer	0.000154	0.00159	CcSEcCtD
Liotrix—Urticaria—Capecitabine—colon cancer	0.00015	0.00154	CcSEcCtD
Liotrix—Abdominal pain—Capecitabine—colon cancer	0.000149	0.00153	CcSEcCtD
Liotrix—Body temperature increased—Capecitabine—colon cancer	0.000149	0.00153	CcSEcCtD
Liotrix—Convulsion—Methotrexate—colon cancer	0.000149	0.00153	CcSEcCtD
Liotrix—Chest pain—Methotrexate—colon cancer	0.000147	0.00151	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—colon cancer	0.000147	0.00151	CcSEcCtD
Liotrix—Confusional state—Methotrexate—colon cancer	0.000142	0.00146	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—colon cancer	0.00014	0.00144	CcSEcCtD
Liotrix—Infection—Methotrexate—colon cancer	0.00014	0.00143	CcSEcCtD
Liotrix—Hypersensitivity—Capecitabine—colon cancer	0.000139	0.00143	CcSEcCtD
Liotrix—Hyperhidrosis—Methotrexate—colon cancer	0.000136	0.0014	CcSEcCtD
Liotrix—Asthenia—Capecitabine—colon cancer	0.000135	0.00139	CcSEcCtD
Liotrix—Anorexia—Methotrexate—colon cancer	0.000134	0.00138	CcSEcCtD
Liotrix—Pruritus—Capecitabine—colon cancer	0.000133	0.00137	CcSEcCtD
Liotrix—ABCB1—lymph node—colon cancer	0.000133	0.00193	CbGeAlD
Liotrix—Hypotension—Methotrexate—colon cancer	0.000131	0.00135	CcSEcCtD
Liotrix—Diarrhoea—Capecitabine—colon cancer	0.000129	0.00133	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000128	0.00131	CcSEcCtD
Liotrix—Insomnia—Methotrexate—colon cancer	0.000127	0.00131	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—colon cancer	0.000126	0.0013	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—colon cancer	0.000125	0.00129	CcSEcCtD
Liotrix—Dizziness—Capecitabine—colon cancer	0.000125	0.00128	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—colon cancer	0.000122	0.00125	CcSEcCtD
Liotrix—Fatigue—Methotrexate—colon cancer	0.000121	0.00124	CcSEcCtD
Liotrix—Vomiting—Capecitabine—colon cancer	0.00012	0.00123	CcSEcCtD
Liotrix—Rash—Capecitabine—colon cancer	0.000119	0.00122	CcSEcCtD
Liotrix—Dermatitis—Capecitabine—colon cancer	0.000119	0.00122	CcSEcCtD
Liotrix—Headache—Capecitabine—colon cancer	0.000118	0.00121	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—colon cancer	0.000116	0.00119	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—colon cancer	0.000115	0.00118	CcSEcCtD
Liotrix—Nausea—Capecitabine—colon cancer	0.000112	0.00115	CcSEcCtD
Liotrix—Urticaria—Methotrexate—colon cancer	0.000112	0.00115	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—colon cancer	0.000111	0.00114	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—colon cancer	0.000111	0.00114	CcSEcCtD
Liotrix—THRA—Endochondral Ossification—VEGFA—colon cancer	0.000108	0.0108	CbGpPWpGaD
Liotrix—Hypersensitivity—Methotrexate—colon cancer	0.000103	0.00106	CcSEcCtD
Liotrix—Asthenia—Methotrexate—colon cancer	0.000101	0.00104	CcSEcCtD
Liotrix—Pruritus—Methotrexate—colon cancer	9.94e-05	0.00102	CcSEcCtD
Liotrix—THRA—Endochondral Ossification—TGFB1—colon cancer	9.93e-05	0.00991	CbGpPWpGaD
Liotrix—TTR—Non-integrin membrane-ECM interactions—TGFB1—colon cancer	9.91e-05	0.00989	CbGpPWpGaD
Liotrix—Diarrhoea—Methotrexate—colon cancer	9.61e-05	0.000987	CcSEcCtD
Liotrix—Dizziness—Methotrexate—colon cancer	9.29e-05	0.000954	CcSEcCtD
Liotrix—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	9.19e-05	0.00918	CbGpPWpGaD
Liotrix—Vomiting—Methotrexate—colon cancer	8.93e-05	0.000918	CcSEcCtD
Liotrix—Rash—Methotrexate—colon cancer	8.86e-05	0.00091	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—colon cancer	8.85e-05	0.000909	CcSEcCtD
Liotrix—Headache—Methotrexate—colon cancer	8.8e-05	0.000904	CcSEcCtD
Liotrix—SLC10A1—Metabolism—CA7—colon cancer	8.56e-05	0.00855	CbGpPWpGaD
Liotrix—Nausea—Methotrexate—colon cancer	8.34e-05	0.000857	CcSEcCtD
Liotrix—THRA—Generic Transcription Pathway—HNF4A—colon cancer	8.33e-05	0.00831	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—HNF4A—colon cancer	8.33e-05	0.00831	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	7.23e-05	0.00722	CbGpPWpGaD
Liotrix—THRA—Endochondral Ossification—AKT1—colon cancer	6.9e-05	0.00689	CbGpPWpGaD
Liotrix—TTR—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	6.64e-05	0.00663	CbGpPWpGaD
Liotrix—TTR—Disease—LGR5—colon cancer	6.27e-05	0.00625	CbGpPWpGaD
Liotrix—TTR—Disease—CHST5—colon cancer	6.27e-05	0.00625	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—CASP3—colon cancer	6.25e-05	0.00624	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—CTNNB1—colon cancer	6.03e-05	0.00601	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	5.82e-05	0.00581	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—EP300—colon cancer	5.6e-05	0.00559	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CA7—colon cancer	5.36e-05	0.00535	CbGpPWpGaD
Liotrix—THRB—SIDS Susceptibility Pathways—VEGFA—colon cancer	5.3e-05	0.0053	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ODC1—colon cancer	5.19e-05	0.00518	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CHST5—colon cancer	5.19e-05	0.00518	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—DLC1—colon cancer	4.67e-05	0.00466	CbGpPWpGaD
Liotrix—TTR—Disease—AXIN2—colon cancer	4.5e-05	0.00449	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—LGR5—colon cancer	4.39e-05	0.00438	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	4.33e-05	0.00432	CbGpPWpGaD
Liotrix—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.3e-05	0.00429	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CA7—colon cancer	4.21e-05	0.00421	CbGpPWpGaD
Liotrix—THRB—Gene Expression—HNF4A—colon cancer	4.01e-05	0.004	CbGpPWpGaD
Liotrix—THRA—Gene Expression—HNF4A—colon cancer	4.01e-05	0.004	CbGpPWpGaD
Liotrix—SLCO4C1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.86e-05	0.00386	CbGpPWpGaD
Liotrix—SLCO4A1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.86e-05	0.00386	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—CDH1—colon cancer	3.82e-05	0.00381	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—PPARG—colon cancer	3.62e-05	0.00361	CbGpPWpGaD
Liotrix—THRA—Generic Transcription Pathway—PPARG—colon cancer	3.62e-05	0.00361	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CA7—colon cancer	3.6e-05	0.0036	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ODC1—colon cancer	3.25e-05	0.00324	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CHST5—colon cancer	3.25e-05	0.00324	CbGpPWpGaD
Liotrix—SLCO1C1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.24e-05	0.00323	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AXIN2—colon cancer	3.15e-05	0.00315	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	2.96e-05	0.00295	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—CASP3—colon cancer	2.92e-05	0.00292	CbGpPWpGaD
Liotrix—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	2.85e-05	0.00285	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CHST5—colon cancer	2.55e-05	0.00255	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ODC1—colon cancer	2.55e-05	0.00255	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.49e-05	0.00248	CbGpPWpGaD
Liotrix—SLC16A10—Transmembrane transport of small molecules—ABCB1—colon cancer	2.35e-05	0.00234	CbGpPWpGaD
Liotrix—TTR—Extracellular matrix organization—TGFB1—colon cancer	2.28e-05	0.00227	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ODC1—colon cancer	2.18e-05	0.00218	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CHST5—colon cancer	2.18e-05	0.00218	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.14e-05	0.00214	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CA7—colon cancer	2.07e-05	0.00207	CbGpPWpGaD
Liotrix—THRA—Generic Transcription Pathway—MYC—colon cancer	2.06e-05	0.00206	CbGpPWpGaD
Liotrix—THRB—Generic Transcription Pathway—MYC—colon cancer	2.06e-05	0.00206	CbGpPWpGaD
Liotrix—ALB—Metabolism—CA7—colon cancer	2.06e-05	0.00206	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.99e-05	0.00199	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.83e-05	0.00183	CbGpPWpGaD
Liotrix—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.83e-05	0.00183	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CA7—colon cancer	1.8e-05	0.0018	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.8e-05	0.0018	CbGpPWpGaD
Liotrix—THRA—Gene Expression—PPARG—colon cancer	1.74e-05	0.00174	CbGpPWpGaD
Liotrix—THRB—Gene Expression—PPARG—colon cancer	1.74e-05	0.00174	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.68e-05	0.00168	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.65e-05	0.00165	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—ABCB1—colon cancer	1.62e-05	0.00162	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CASP3—colon cancer	1.6e-05	0.0016	CbGpPWpGaD
Liotrix—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.58e-05	0.00158	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.57e-05	0.00156	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—VEGFA—colon cancer	1.53e-05	0.00153	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.53e-05	0.00152	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.47e-05	0.00147	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.46e-05	0.00146	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.44e-05	0.00144	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—TGFB1—colon cancer	1.41e-05	0.0014	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.4e-05	0.0014	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—ABCB1—colon cancer	1.37e-05	0.00137	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.36e-05	0.00135	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TP53—colon cancer	1.35e-05	0.00135	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—TYMS—colon cancer	1.35e-05	0.00134	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.34e-05	0.00134	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.34e-05	0.00134	CbGpPWpGaD
Liotrix—TTR—Disease—FGFR3—colon cancer	1.3e-05	0.0013	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CHST5—colon cancer	1.25e-05	0.00125	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ODC1—colon cancer	1.25e-05	0.00125	CbGpPWpGaD
Liotrix—ALB—Metabolism—ODC1—colon cancer	1.25e-05	0.00125	CbGpPWpGaD
Liotrix—ALB—Metabolism—CHST5—colon cancer	1.25e-05	0.00125	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.25e-05	0.00124	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.23e-05	0.00123	CbGpPWpGaD
Liotrix—TTR—Disease—APC—colon cancer	1.19e-05	0.00119	CbGpPWpGaD
Liotrix—TTR—Disease—BRAF—colon cancer	1.12e-05	0.00112	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.12e-05	0.00112	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ODC1—colon cancer	1.09e-05	0.00109	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CHST5—colon cancer	1.09e-05	0.00109	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.06e-05	0.00105	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.05e-05	0.00105	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.04e-05	0.00103	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1e-05	0.000998	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MYC—colon cancer	9.93e-06	0.000991	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MYC—colon cancer	9.93e-06	0.000991	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PPARG—colon cancer	9.54e-06	0.000952	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGFR3—colon cancer	9.1e-06	0.000909	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—colon cancer	9.06e-06	0.000905	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.01e-06	0.0009	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.78e-06	0.000876	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ABCB1—colon cancer	8.59e-06	0.000857	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	8.5e-06	0.000848	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—TYMS—colon cancer	8.43e-06	0.000842	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—APC—colon cancer	8.36e-06	0.000834	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.29e-06	0.000828	CbGpPWpGaD
Liotrix—TTR—Disease—CTNNB1—colon cancer	8.11e-06	0.000809	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1A—colon cancer	7.92e-06	0.000791	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.89e-06	0.000788	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—BRAF—colon cancer	7.86e-06	0.000784	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.68e-06	0.000767	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.6e-06	0.000759	CbGpPWpGaD
Liotrix—TTR—Disease—EP300—colon cancer	7.54e-06	0.000752	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—colon cancer	7.5e-06	0.000749	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	7.43e-06	0.000742	CbGpPWpGaD
Liotrix—TTR—Disease—SRC—colon cancer	7.33e-06	0.000732	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.09e-06	0.000708	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	7.07e-06	0.000706	CbGpPWpGaD
Liotrix—TTR—Disease—NRAS—colon cancer	7.05e-06	0.000704	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	7.04e-06	0.000703	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	6.98e-06	0.000697	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.9e-06	0.000688	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—colon cancer	6.88e-06	0.000687	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—colon cancer	6.88e-06	0.000687	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.87e-06	0.000686	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	6.8e-06	0.000679	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ABCB1—colon cancer	6.75e-06	0.000673	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.7e-06	0.000668	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TYMS—colon cancer	6.63e-06	0.000661	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—colon cancer	6.57e-06	0.000656	CbGpPWpGaD
Liotrix—TTR—Disease—TGFB1—colon cancer	6.55e-06	0.000654	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.49e-06	0.000648	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—colon cancer	6.42e-06	0.000641	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—EP300—colon cancer	6.24e-06	0.000623	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	6.24e-06	0.000623	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	6.16e-06	0.000615	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	6.14e-06	0.000613	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—colon cancer	6.07e-06	0.000606	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.02e-06	0.000601	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—colon cancer	5.97e-06	0.000596	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.9e-06	0.000589	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—colon cancer	5.89e-06	0.000588	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—colon cancer	5.77e-06	0.000576	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—colon cancer	5.73e-06	0.000572	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.69e-06	0.000568	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—colon cancer	5.68e-06	0.000567	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—colon cancer	5.67e-06	0.000566	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—colon cancer	5.58e-06	0.000557	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—colon cancer	5.55e-06	0.000554	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	5.31e-06	0.00053	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—colon cancer	5.28e-06	0.000527	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.23e-06	0.000522	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.18e-06	0.000517	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—colon cancer	5.16e-06	0.000515	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.15e-06	0.000514	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—colon cancer	5.13e-06	0.000512	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.1e-06	0.000509	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.06e-06	0.000505	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—colon cancer	5e-06	0.000499	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—colon cancer	4.94e-06	0.000493	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—colon cancer	4.7e-06	0.000469	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—colon cancer	4.69e-06	0.000469	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—colon cancer	4.62e-06	0.000461	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—colon cancer	4.6e-06	0.000459	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—colon cancer	4.59e-06	0.000458	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—colon cancer	4.55e-06	0.000455	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—colon cancer	4.5e-06	0.000449	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.36e-06	0.000435	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	4.34e-06	0.000433	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.27e-06	0.000426	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—colon cancer	4.25e-06	0.000424	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.07e-06	0.000407	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.05e-06	0.000404	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—colon cancer	4.01e-06	0.000401	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—colon cancer	3.91e-06	0.00039	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—colon cancer	3.9e-06	0.00039	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—colon cancer	3.78e-06	0.000377	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—colon cancer	3.77e-06	0.000376	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—colon cancer	3.7e-06	0.000369	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—colon cancer	3.69e-06	0.000369	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—colon cancer	3.61e-06	0.000361	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—colon cancer	3.6e-06	0.000359	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—colon cancer	3.5e-06	0.00035	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—colon cancer	3.46e-06	0.000346	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.39e-06	0.000338	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.37e-06	0.000336	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—colon cancer	3.32e-06	0.000331	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—colon cancer	3.3e-06	0.000329	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—colon cancer	3.26e-06	0.000325	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—colon cancer	3.24e-06	0.000323	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—colon cancer	3.22e-06	0.000321	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—colon cancer	3.19e-06	0.000318	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—colon cancer	3.16e-06	0.000315	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—colon cancer	3.07e-06	0.000307	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—colon cancer	2.98e-06	0.000297	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—colon cancer	2.89e-06	0.000289	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—colon cancer	2.84e-06	0.000283	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—colon cancer	2.74e-06	0.000273	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—colon cancer	2.65e-06	0.000264	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—colon cancer	2.63e-06	0.000262	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—colon cancer	2.53e-06	0.000253	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.51e-06	0.00025	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.49e-06	0.000249	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—colon cancer	2.36e-06	0.000236	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—colon cancer	2.31e-06	0.00023	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—colon cancer	2.29e-06	0.000229	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—colon cancer	2.27e-06	0.000227	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—colon cancer	2.24e-06	0.000223	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—colon cancer	2.01e-06	0.000201	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—colon cancer	1.94e-06	0.000194	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—colon cancer	1.86e-06	0.000185	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—colon cancer	1.81e-06	0.000181	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—colon cancer	1.8e-06	0.00018	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—colon cancer	1.59e-06	0.000158	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—colon cancer	1.58e-06	0.000158	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—colon cancer	1.51e-06	0.000151	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—colon cancer	1.5e-06	0.00015	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—colon cancer	1.31e-06	0.000131	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—colon cancer	1.12e-06	0.000111	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—colon cancer	1.11e-06	0.000111	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—colon cancer	9.72e-07	9.71e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—colon cancer	9.12e-07	9.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—colon cancer	9.07e-07	9.05e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—colon cancer	7.94e-07	7.93e-05	CbGpPWpGaD
